Pretoria – Aspen Pharmacare, Southern Africa’s largest generics manufacturer and JSE Securities Exchange listed pharmaceutical company, has announced the launch of Aspen-Stavudine – the first generic antiretroviral (ARV) drug developed and manufactured in Africa. Stephen Saad, Aspen Pharmacare Group Chief Executive Officer said “Aspen-Stavudine is the first locally developed and manufactured generic ARV which presents… Continue reading Aspen manufactures Africa’s first generic ARVs
Aspen will be in a closed period from 1 January 2025 until the publication of the Interim Results on the JSE SENS platform on 3 March 2025.
